NVO - Novo Nordisk to invest $2.3B to ramp up weight-loss drug production in France
2023-11-24 05:25:24 ET
- Novo Nordisk to ration Ozempic starter kits amid weight loss use
- Novo Nordisk (NVO) R&D Investor Event (Transcript)
- Novo Nordisk: Price Could Still Be Justified
- Novo Nordisk (NVO) Q3 Earnings Call Transcript
- M&A, GLP-1s to dominate healthcare themes in 2024 as COVID fades
For further details see:
Novo Nordisk to invest $2.3B to ramp up weight-loss drug production in France